Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ELCOS GOLD
- Development stage
- Unknown
- Lead developer
- Captab Biotec
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Peptides
- Administration
- Oral
01
Overview
ELCOS GOLD (also written as ELCOS-GOLD) is a multi-ingredient nutraceutical softgel capsule developed and marketed by Captab Biotec. It is formulated to support joint health and manage orthopedic conditions such as osteoarthritis and joint pain. The combination contains several active ingredients, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), sodium hyaluronate (hyaluronic acid), collagen type II, rosehip extract, curcumin, piperine (Bioperine), and cetyl myristoleate (esterified fatty acid complex). These components work synergistically to reduce inflammation, support cartilage structure, improve joint lubrication, and alleviate pain associated with degenerative joint disorders.
- Brand names
- ELCOS GOLDELCOS-GOLD
- Other names
- cetyl myristoleate + collagen type II + curcumin + docosahexaenoic acid + eicosapentaenoic acid + piperine + rosehip extract + sodium hyaluronateepa + dha + sodium hyaluronate + collagen peptide II + rosehip + curcumin + piperine
02
Targets
CD44 (CD44 antigen)COL2 (Type II Collagen)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)FFAR4 (Free fatty acid receptor 4)
Beyond the preview
Go deeper on ELCOS GOLD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ELCOS GOLD.